Bristol-Myers taps Anthropic's Claude for 30,000 workers (BMY:NYSE)
Bristol-Myers Squibb ( BMY ) is rolling out Anthropic ’s ( ANTHRO ) flagship Claude AI platform to more than 30,000 employees, expanding its use of artificial intelligence and AI agents across research, clinical development, and corporate operations. The collaboration signals a meaningful evolution in how the company leverages AI to drive innovation and efficiency. This initiative underscores Bristol-Myers Squibb's commitment to integrating advanced technologies into its core operations, aiming to enhance productivity and accelerate the development of new therapies. By deploying Claude, the company seeks to streamline workflows, improve decision-making processes, and foster a culture of continuous improvement. This move is part of a broader trend in the pharmaceutical industry, where AI is increasingly being adopted to transform traditional practices and unlock new opportunities for growth and innovation.
Source: Seeking Alpha